Hudson Medical Report issue

For profit Phase 1
Founded: New York City New York United States (2010)

Organization Overview

First Clinical Trial
2022
NCT05638620
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Hudson Medical